Real-time data interoperability in the COVID-19 era
The COVID-19 outbreak has created an unprecedented need for real-time data. As the global pandemic...
How the FDA is using real-world evidence in safety and approval decisions
Regulatory decision-making depends on evidence that reflects how medical products perform in real-world use, not only in controlled trials. For more than a decade, the Food and Drug Administration has relied on real-world data and real-world...
Making decisions with real-world evidence and COVID-19
The COVID-19 pandemic has triggered intense and widespread action among the biopharma industry and...
Beyond COVID-19 with HealthVerity Patient Confidence Index
The coronavirus pandemic continues to be a disruptive force for patients and physicians across the...
Removing gaps in the patient journey with closed payer claims
Patient centricity is top of mind for life sciences companies today. In order to put the patient at...
How healthcare marketing is catching up
Healthcare has the lowest digital ad spend among major industries today. Privacy protection laws...
Putting data to work for value-based agreements
Complex medical treatments like gene and immunotherapies have brought us into a new era of...
CCPA: Connected devices and new privacy regulations
Connected devices are here to stay. The conveniences they offer can make it easy to forget just how...
Countdown to the CCPA: What Financial Services Industry Must Know
By: John Chaisson, Data Privacy & Blockchain,HealthVerity Perhaps no other industry is as heavily...
A new acronym and privacy considerations in the healthcare industry
HIPAA (Health Insurance Portability and Accountability Act) has long been the acronym synonymous...
The risks of false negatives in healthcare data linkage
Part 3: Measuring false negatives in anonymized healthcare data [Part 3] ofMatching Accuracy...